ArticleESMO open2023

Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy.

Y-J Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.